about
Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus populationEvolution of Streptococcus pneumoniae and its close commensal relatives.Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin.Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae.Emergence and global dissemination of host-specific Streptococcus agalactiae clones.Method for quantitative detection and presumptive identification of group B streptococci on primary platingInternational external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci)Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants.Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutinationCross-reactions between pneumococci and other streptococci due to C polysaccharide and F antigen.Capsular Polysaccharide Expression in Commensal Streptococcus Species: Genetic and Antigenic Similarities to Streptococcus pneumoniae.IgG subclass profiles in normal human sera of antibodies specific to five kinds of microbial antigens.Prevention of invasive bacterial diseases by immunization with polysaccharide-protein conjugates.Typing of pneumococci by using 12 pooled antisera.Functional and structural insight into properdin control of complement alternative pathway amplification.Pneumococcal polysaccharide antigens: capsules and C-polysaccharide. An immunochemical study.Ectodermal dysplasia with immunodeficiency caused by a branch-point mutation in IKBKG/NEMO.Temperature limitation may explain the containment of the trophozoites in the cornea during Acanthamoeba castellanii keratitis.Correction for Jensen et al., Timing of Toll-Like Receptor 9 Agonist Administration in Pneumococcal Vaccination Impacts Both Humoral and Cellular Immune Responses as Well as Nasopharyngeal Colonization in Mice.The Immunomodulatory Drug Glatiramer Acetate is Also an Effective Antimicrobial Agent that Kills Gram-negative Bacteria.Correction: Evolution of Streptococcus pneumoniae and Its Close Commensal Relatives.[Ascariasis is a zoonosis in Denmark--secondary publication].M-Ficolin Binds Selectively to the Capsular Polysaccharides ofStreptococcus pneumoniae Serotypes 19B and 19C and of a Streptococcus mitis StrainCurvature of Synthetic and Natural Surfaces Is an Important Target Feature in Classical Pathway Complement ActivationThe chemical structures of the capsular polysaccharides from Streptococcus pneumoniae types 32F and 32AStructural elucidation of the capsular polysaccharide from Streptococcus pneumoniae type 18BA modified enzyme-linked immunosorbent assay for measuring type-specific anti-pneumococcal capsular polysaccharide antibodiesAntibodies against pneumococcal C-polysaccharide are not protectiveC-polysaccharide in a pneumococcal vaccineThe distribution of clones of Streptococcus agalactiae (group B streptococci) among herdspersons and dairy cows demonstrates lack of host specificity for some lineages
P50
Q28547039-495B71B2-0927-4DCF-86DC-D2E95430CFFAQ33351980-8A0121C8-1C33-4DD4-A99A-8F8DF66CCA0BQ33795274-D31F79D7-F784-4EA4-A5B2-EEE851BF419FQ33867105-E15AAC92-FBAD-4EA1-A545-92D78B1FB655Q34100077-B8FF9D34-45B7-4060-981B-01849DAC9278Q34974094-D1ABC040-E6A1-4EC6-AC8D-EBB2AC919DBDQ35066957-9F8594AF-D081-48B8-9F61-6D8843E5CD0CQ35552608-48456995-91B9-4768-A475-058CC3F0440CQ36559104-4FBE9A7A-1D8F-44B5-B8E6-F0469F8B27A9Q37220192-60A3B7CE-53F3-41DE-894E-EC7F1366B038Q37417367-4D87E985-0740-4B29-9703-56F6FF9655A9Q37846623-D8E0E50B-B946-40B9-A4F7-CBDB9E6E8731Q38642497-D42194A1-03C4-4926-91CF-677EA48E4E11Q40188454-E92B6F83-6E39-4780-80C5-5A10E1F23FBBQ40306147-3E5CD5F5-BB81-4F41-8A2C-421F0F05DADCQ40513318-E2E9E0FA-056F-44DB-A16B-9424A4986660Q40593759-7C3CED0C-F656-467A-A709-35F8CFA45C6AQ41746008-CAC115B1-5355-4349-A44E-54C28C70957FQ46914466-48064351-4712-40AD-A7E1-6C1098F73760Q47102307-4BC5BAA0-C2B5-4CEF-A5C5-C30088E99475Q47128782-5F25F452-8656-4FE3-BB8A-DD2BE453DF2EQ50543024-E47D96FC-135F-4F89-8136-31A6704CF461Q60470393-E8077392-75AE-436D-9DBB-D57E76691F23Q60470434-82AAC5C0-8470-4C45-8BBB-1C1EBDC39351Q60470479-2F79746B-B48F-4DC1-8FB9-0E426D204E8FQ60470486-EC86E56F-C8C6-4DEE-83E4-29789D81D20CQ60470500-496194A6-F083-4C32-A55E-90B2108A14ECQ60470511-3D9EA753-4E48-4FB8-8809-FBB159BB7FC7Q60470555-27571031-8FC0-43B2-9981-36C738C6D204Q91697547-F34DB165-43DE-40A0-A8B5-F0E103D2316D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Uffe B Skov Sørensen
@ast
Uffe B Skov Sørensen
@en
Uffe B Skov Sørensen
@es
Uffe B Skov Sørensen
@nl
Uffe B Skov Sørensen
@sl
type
label
Uffe B Skov Sørensen
@ast
Uffe B Skov Sørensen
@en
Uffe B Skov Sørensen
@es
Uffe B Skov Sørensen
@nl
Uffe B Skov Sørensen
@sl
prefLabel
Uffe B Skov Sørensen
@ast
Uffe B Skov Sørensen
@en
Uffe B Skov Sørensen
@es
Uffe B Skov Sørensen
@nl
Uffe B Skov Sørensen
@sl
P106
P1153
6603776740
P31
P496
0000-0002-6777-054X